Discontinuation report ENBREL
Report ID | 168157 |
Drug Identification Number | 02242903 |
Brand name | ENBREL |
Common or Proper name | etanercept for injection |
Company Name | IMMUNEX CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | WATER ETANERCEPT |
Strength(s) | 1ML 25MG |
Dosage form(s) | POWDER FOR SOLUTION LIQUID KIT |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 25 mg/vial |
ATC code | L04AB |
ATC description | IMMUNOSUPPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-12-15 |
Actual discontinuation date | 2022-12-14 |
Remaining supply date | 2022-12-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ONE AMGEN CENTRE DRIVE THOUSAND OAKS, CALIFORNIA UNITED STATES 91320-1799 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-01-13 | French | Compare |
v5 | 2023-01-13 | English | Compare |
v4 | 2022-10-18 | French | Compare |
v3 | 2022-10-18 | English | Compare |
v2 | 2022-08-29 | French | Compare |
v1 | 2022-08-29 | English | Compare |
Showing 1 to 6 of 6